How to handle non-conformities and get back on track

Dr Will Brambley
Turning blocks from crosses to ticks

In the highly regulated world of regulatory affairs, technical documentation serves as a cornerstone for ensuring product compliance, safety, and efficacy. Yet even the most meticulously prepared documents can face non-conformities during review.

This article is published in partnership with Cyber Alchemy. Mantra Systems specialises in medical device regulatory strategy and technical documentation for UK and EU MDR/IVDR pathways. Cyber Alchemy focuses on cybersecurity, helping teams develop and evidence security for software-enabled and connected medical devices. Together, we’re producing a practical series for MedTech teams: what to build, what to defer, and how to avoid avoidable rework when moving between UK, NHS procurement, and EU routes.

What is a non-conformity and why do they happen?

In the context of the EU Medical Device Regulation (EU MDR), a non-conformance refers to a situation where a medical device, process, or quality management system does not meet the requirements outlined in the regulation (EU MDR, ISO 13485) and the organisation’s aligned procedures. Non-conformities can occur during numerous stages of the medical device lifecycle, including design, manufacturing, post-market surveillance, or quality management, and may include:

  • Clinical data gaps
  • Inappropriate equivalence claims
  • Incomplete or inaccurate document content
  • Use of outdated or superseded regulations or standards

Non-conformities can significantly disrupt the approval process, leading to extended review timelines, increased costs, and further revision cycles. Since Notified Bodies cannot accept a technical file with unresolved non-conformities, correcting them is critical for market access.

In my experience many non-conformities, particularly those relating to clinical evaluation or risk management, arise because the technical file is disjointed and does not tell a coherent story. The technical file is not simply a library of information relating to a device. It should guide a reviewer through the life of the device from conceptualisation right through to pre-clinical and clinical testing of a device, while clearly demonstrating safety, performance and an acceptable benefit-risk profile.

Common non-conformities for SaMDs

Quality Management

  • Lack of evidence that existing procedures have been followed
  • Lack of design controls for software changes
  • Poor documentation of suppliers and Software of Unknown Provenance (SOUP)
  • Ineffective Corrective and Preventive Action (CAPA) system

Clinical evaluation and evidence gaps

Software lifecycle documentation which falls short of the standards of IEC 62304

  • Missing or incomplete software development plan
  • Poor traceability between user requirements, design, verification and validation
  • Lack of detail in the documentation of software architecture
  • Insufficient verification & validation evidence
  • Poor SOUP version control

Risk Management

  • Risk files not updated throughout device lifecycle
  • Poor linkage between hazards, risks, controls, and verification
  • Missing software-specific risks (e.g., cybersecurity, data corruption, incorrect outputs)
  • Lack of a quantitative benefit-risk analysis

Issues with Annex II/III documentation

  • Unclear or vague intended purpose statement
  • Unclear post-market surveillance plan or procedure

How to address non-conformities

The first step to addressing non-conformities is to have a clear discussion with your Notified Body about the non-conformities that they have raised. Notified Bodies are obligated to communicate non-conformities to you, but there is no legislative requirement for them to provide a video-call or structured dialogue discussion, so it’s worth knowing whether your Notified Body offers this before starting the assessment process.

During a discussion about non-conformities, your Notified Body can only offer clarification, as opposed to recommendations or guidance about how to fix them. They can give you more detail as to why an issue has been flagged, but they can’t tell you exactly how to fix them.

Once you have the non-conformity report from the Notified Body, I always recommend creating your own summary list of non-conformities that will need to be addressed. Formats for these reports vary between Notified Bodies and can be confusing sometimes.

With your summary list, you can group non-conformities together and identify solutions which may address multiple issues. You can also clearly assign each non-conformity a solution and a team member to action it.

Notified Bodies will give you a timeline for response and resubmission of your documents. Where you feel that you require more time to adequately address deficiencies, you should ask for an extension to the timeline early on.

Free 30-minute review call

If you’re still unclear about how to address non‑conformities, engaging expert support can be the most effective way to navigate the review process and achieve your UKCA or CE mark. When deficiencies span both regulatory and cybersecurity domains, no single perspective is enough.

That’s why Mantra Systems and Cyber Alchemy are offering a free 30-minute joint review, so you get a complete picture of your technical file and cybersecurity gaps, and a clear, actionable recovery plan in one conversation.

Claim your free 30-minute review

Related articles

  1. US and EU flags on poles alongside each other.

    Clinical Evidence under EU MDR: Leveraging FDA Clinical Data to Streamline EU MDR Compliance

    FDA approval alone is not sufficient for European market access - a theme we explore futher in this article and the accompanying webinar.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  2. An AI-generated image of 3 people in an office in front of a whiteboard with the words 'Medical Device Market Entry Strategy' written above a world map.

    EU MDR & NHS DTAC Cybersecurity Requirements for UK Market Entry

    This guest article from our partner Cyber Alchemy shows you how to build cybersecurity evidence for the EU MDR and NHS DTAC.

    Luke Hill Luke Hill Co-Founder of Cyber Alchemy
  3. An illustration showing a GPS-driven navigation route superimposed upon someone using a laptop.

    Where to Launch First? A MedTech Founder's Regulatory Roadmap to the EU, UK and US

    Cyber Alchemy × Mantra Systems — Episode 1: All three markets operate under different regulatory systems and place different demands on manufacturers.

    Ronghe Xu Ronghe Xu Regulatory Medical Writer & Strategic BD Lead China
  4. A woman uses an inhaler.

    Navigating EU MDR Article 117: A Practical Guide to Drug-Device Combination Product Submissions

    Implementation of the EU MDR 2017/745 has brought significant changes.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  5. Collage art showing a pair of binoculars, an analogy for surveillance.

    How EU MDR Post Market Surveillance differs from FDA post-market expectations

    We compare manufacturer-specific post-market obligations across both regulatory systems.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  6. An arrow arcs from the US over to Europe.

    How EU device classification differs from the US - Are you Prepared?

    Did you know an FDA Class II medical device could be immediately considered as a high-risk Class III device under European Union regulations?

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer
  7. A magnifying glass inspecting a number of wooden cubes with question marks upon them laid upon a blue table. The wooden cube under the magnifying glass has a lightbulb painted on it.

    Fixing the MDR and IVDR? The Commission’s Proposed Amendments and What They Mean for Manufacturers

    Exploring the key elements of this proposal.

    Chandini Valiya Kizhakkeveetil Chandini Valiya Kizhakkeveetil Regulatory Medical Writer
  8. Two arms point at a sign and hold a question mark, in an abstract pop-art style.

    Regulatory Reset? The EU’s Proposed Changes to MDR and IVDR Explained

    Changes published in December 2025 aim to streamline EU medical device and in vitro diagnostics. We explain who is impacted and how.

    Dr Gayle Buchel Dr Gayle Buchel Chief Medical Writer
  9. A pair of glasses rests on an eye test chart.

    Did You Know Your Glasses Were a Medical Device? A Regulatory Guide for Manufacturers

    The importance of correct classification and our recommended path to avoid common ophthalmic device 'gotchas'.

    Gabriela Cardoso Gabriela Cardoso Regulatory Medical Writer

More articles

Need help producing compliant CEPs & CERs? We are offering FREE CEPs to 5 qualifying applicants per week

Get your free CEP